Filing Details
- Accession Number:
- 0001209191-17-054194
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-27 21:38:49
- Reporting Period:
- 2017-09-25
- Accepted Time:
- 2017-09-27 21:38:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1510580 | Kite Pharma Inc. | KITE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222082 | M Cynthia Butitta | C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-25 | 8,000 | $0.00 | 125,795 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-09-25 | 4,228 | $179.66 | 121,567 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.